Differentiation potential and functional properties of a CD34‑CD133+ subpopulation of endothelial progenitor cells

Bachelier,Katrin; Bergholz,Carolin; Friedrich,Erik  B.

doi:10.3892/mmr.2019.10831

Differentiation potential and functional properties of a CD34‑CD133+ subpopulation of endothelial progenitor cells

Authors:
- Katrin Bachelier
- Carolin Bergholz
- Erik B. Friedrich
View Affiliations

Affiliations: Clinic of Internal Medicine III, Cardiology, Angiology and Intensive Care, University of The Saarland, D‑66421 Homburg/Saar, Germany
Published online on: November 20, 2019 https://doi.org/10.3892/mmr.2019.10831
Pages: 501-507

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Endothelial progenitor cells (EPCs) promote angiogenesis and play an important role in myocardial and vascular repair after ischemia and infarction. EPCs consist of different subpopulations including CD34‑CD133+ EPCs, which are precursors of more mature CD34+CD133+ EPCs and functionally more active in terms of homing and endothelial regeneration. In the present study we analyzed the functional and differentiation abilities of CD34‑CD133+ EPCs. Isolation of EPC populations (CD34+CD133+, CD34‑CD133+) were performed by specific multi‑step magnetic depletion. After specific stimulation a significant higher adhesive and migrative capacity of CD34‑CD133+ cells could be detected compared to CD34+CD133+ cells (P<0.001, respectively). Next to this finding, not only significantly higher rates of proliferation (P<0.005) were detected among CD34‑CD133+ cells, but also a higher potential of cell‑differentiation capacity into other cell types. Next to a significant increase of CD34‑CD133+ EPCs differentiating into a fibroblast cell‑type (P<0.001), an enhancement into a hepatocytic cell‑type (P=0.033) and a neural cell‑type (P=0.016) could be measured in contrast to CD34+CD133+ cells. On the other hand, there was no significant difference in differentiation into a cardiomyocyte cell‑type between these EPC subpopulations (P=0.053). These results demonstrate that EPC subpopulations vary in their functional abilities and, to different degrees, have the capacity to transdifferentiate into unrelated cell‑types such as fibroblasts, hepatocytes, and neurocytes. This indicates that CD34‑CD133+ cells are more pluripotent compared to the CD34+CD133+ EPC subset, which may have important consequences for the therapy of vascular diseases.

View Figures

View References

1	Chopra H, Hung MK, Kwong DL, Zhang CF and Pow EHN: Insights into endothelial progenitor cells: Origin, classification, potentials, and prospects. Stem Cells Int. 2018:98470152018. View Article : Google Scholar : PubMed/NCBI
2	Salybekov AA, Kawaguchi AT, Masuda H, Vorateera K, Okada C and Asahara T: Regeneration-associated cells improve recovery from myocardial infarction through enhanced vasculogenesis, anti-inflammation, and cardiomyogenesis. PLoS One. 13:e02032442018. View Article : Google Scholar : PubMed/NCBI
3	Mudyanadzo TA: Endothelial progenitor cells and cardiovascular correlates. Cureus. 10:e33422018.PubMed/NCBI
4	Silvestre JS, Mallat Z, Tedgui A and Lévy BI: Post-ischaemic neovascularization and inflammation. Cardiovasc Res. 78:242–249. 2008. View Article : Google Scholar : PubMed/NCBI
5	Jones DA, Weeraman D, Colicchia M, Hussain MA, Veerapen D, Andiapen M, Rathod KS, Baumbach A and Mathur A: Impact of cell therapy on cardiovascular outcomes in patients with refractory angina. Circ Res. 124:1786–1795. 2019. View Article : Google Scholar : PubMed/NCBI
6	Friedrich EB, Walenta K, Scharlau J, Nickenig G and Werner N: CD34-/CD133+/VEGFR-2+ endothelial progenitor cell subpopulation with potent vasoregenerative capacities. Circ Res. 98:e20–e25. 2006. View Article : Google Scholar : PubMed/NCBI
7	Hristov M, Zernecke A, Liehn EA and Weber C: Regulation of endothelial progenitor cell homing after arterial injury. Thromb Haemost. 98:274–277. 2007. View Article : Google Scholar : PubMed/NCBI
8	Urbich C and Dimmeler S: Endothelial progenitor cells: Characterization and role in vascular biology. Circ Res. 95:343–353. 2004. View Article : Google Scholar : PubMed/NCBI
9	Walenta K, Friedrich EB, Sehnert F, Werner N and Nickenig G: In vitro differentiation characteristics of cultured human mononuclear cells-implications for endothelial progenitor cell biology. Biochem Biophys Res Commun. 333:476–482. 2005. View Article : Google Scholar : PubMed/NCBI
10	Steinhoff G, Nesteruk J, Wolfien M, Kundt G; PERFECT Trial Investigators Group, ; Börgermann J, David R, Garbade J, Große J, Haverich A, et al: Cardiac function improvement and bone marrow response -: Outcome analysis of the randomized PERFECT phase III clinical trial of intramyocardial CD133+ application after myocardial infarction. EBioMedicine. 22:208–224. 2017. View Article : Google Scholar : PubMed/NCBI
11	Correa A, Ottoboni GS, Senegaglia AC, Capriglione LGA, Miyague NI, Leite LMB, Jamur VR, Rebelatto CLK, Olandoski M and Brofman PRS: Expanded CD133+ cells from human umbilical cord blood improved heart function in rats after severe myocardial infarction. Stem Cells Int. 2018:54124782018. View Article : Google Scholar : PubMed/NCBI
12	Werner N and Nickenig G: Clinical and therapeutical implications of EPC biology in atherosclerosis. J Cell Mol Med. 10:318–332. 2006. View Article : Google Scholar : PubMed/NCBI
13	Walenta KL, Bettink S, Böhm M and Friedrich EB: Differential chemokine receptor expression regulates functional specialization of endothelial progenitor cell subpopulations. Basic Res Cardiol. 106:299–305. 2011. View Article : Google Scholar : PubMed/NCBI
14	Kaiser R, Friedrich D, Chavakis E, Böhm M and Friedrich EB: Effect of hypoxia on integrin-mediated adhesion of endothelial progenitor cells. J Cell Mol Med. 16:2387–2393. 2012. View Article : Google Scholar : PubMed/NCBI
15	Jung C, Fischer N, Fritzenwanger M, Thude H, Ferrari M, Fabris M, Brehm BR, Barz D and Figulla HR: Endothelial progenitor cells in adolescents: Impact of overweight, age, smoking, sport and cytokines in younger age. Clin Res Cardiol. 98:179–188. 2009. View Article : Google Scholar : PubMed/NCBI
16	Lagasse E, Connors H, Al-Dhalimy M, Reitsma M, Dohse M, Osborne L, Wang X, Finegold M, Weissman IL and Grompe M: Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med. 6:1229–1234. 2000. View Article : Google Scholar : PubMed/NCBI
17	Brazelton TR, Rossi FM, Keshet GI and Blau HM: From marrow to brain: Expression of neuronal phenotypes in adult mice. Science. 290:1775–1779. 2000. View Article : Google Scholar : PubMed/NCBI
18	Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, Pickel J, McKay R, Nadal-Ginard B, Bodine DM, et al: Bone marrow cells regenerate infarcted myocardium. Nature. 410:701–705. 2001. View Article : Google Scholar : PubMed/NCBI
19	Müller P, Pfeiffer P, Koglin J, Schäfers HJ, Seeland U, Janzen I, Urbschat S and Böhm M: Cardiomyocytes of noncardiac origin in myocardial biopsies of human transplanted hearts. Circulation. 106:31–35. 2002. View Article : Google Scholar : PubMed/NCBI
20	Deb A, Wang S, Skelding KA, Miller D, Simper D and Caplice NM: Bone marrow-derived c.ardiomyocytes are present in adult human heart: A study of gender-mismatched bone marrow transplantation patients. Circulation. 107:1247–1249. 2003. View Article : Google Scholar : PubMed/NCBI
21	Badorff C, Brandes RP, Popp R, Rupp S, Urbich C, Aicher A, Fleming I, Busse R, Zeiher AM and Dimmeler S: Transdifferentiation of blood-derived human adult endothelial progenitor cells into functionally active cardiomyocytes. Circulation. 107:1024–1032. 2003. View Article : Google Scholar : PubMed/NCBI
22	Koyanagi M, Urbich C, Chavakis E, Hoffmann J, Rupp S, Badorff C, Zeiher AM, Starzinski-Powitz A, Haendeler J and Dimmeler S: Differentiation of circulating endothelial progenitor cells to a cardiomyogenic phenotype depends on E-cadherin. FEBS Lett. 579:6060–6066. 2005. View Article : Google Scholar : PubMed/NCBI
23	Friedrich EB, Werner C, Walenta K, Böhm M and Scheller B: Role of extracellular signal-regulated kinase for endothelial progenitor cell dysfunction in coronary artery disease. Basic Res Cardiol. 104:613–620. 2009. View Article : Google Scholar : PubMed/NCBI
24	Werner C, Böhm M and Friedrich EB: Role of integrin-linked kinase for functional capacity of endothelial progenitor cells in patients with stable coronary artery disease. Biochem Biophys Res Commun. 377:331–336. 2008. View Article : Google Scholar : PubMed/NCBI
25	Friedrich EB, Tager AM, Liu E, Pettersson A, Owman C, Munn L, Luster AD and Gerszten RE: Mechanisms of leukotriene B4-triggered monocyte adhesion. Arterioscler Thromb Vasc Biol. 23:1761–1767. 2003. View Article : Google Scholar : PubMed/NCBI
26	Ge Q, Zhang H, Hou J, Wan L, Cheng W, Wang X, Dong D, Chen C, Xia J, Guo J, et al: VEGF secreted by mesenchymal stem cells mediates the differentiation of endothelial progenitor cells into endothelial cells via paracrine mechanisms. Mol Med Rep. 17:1667–1675. 2018.PubMed/NCBI
27	Rossi E, Smadja D, Goyard C, Cras A, Dizier B, Bacha N, Lokajczyk A, Guerin CL, Gendron N, Planquette B, et al: Co-injection of mesenchymal stem cells with endothelial progenitor cells accelerates muscle recovery in hind limb ischemia through an endoglin-dependent mechanism. Thromb Haemost. 117:1908–1918. 2017. View Article : Google Scholar : PubMed/NCBI
28	Rossi E, Smadja DM, Boscolo E, Langa C, Arevalo MA, Pericacho M, Gamella-Pozuelo L, Kauskot A, Botella LM, Gaussem P, et al: Endoglin regulates mural cell adhesion in the circulatory system. Cell Mol Life Sci. 73:1715–1739. 2016. View Article : Google Scholar : PubMed/NCBI
29	Koutna I, Peterkova M, Simara P, Stejskal S, Tesarova L and Kozubek M: Proliferation and differentiation potential of CD133+ and CD34+ populations from the bone marrow and mobilized peripheral blood. Ann Hematol. 90:127–137. 2011. View Article : Google Scholar : PubMed/NCBI
30	Fritzenwanger M, Lorenz F, Jung C, Fabris M, Thude H, Barz D and Figulla HR: Differential number of CD34+, CD133+ and CD34+/CD133+ cells in peripheral blood of patients with congestive heart failure. Eur J Med Res. 14:113–117. 2009.PubMed/NCBI
31	Yao W, Firth AL, Sacks RS, Ogawa A, Auger WR, Fedullo PF, Madani MM, Lin GY, Sakakibara N, Thistlethwaite PA, et al: Identification of putative endothelial progenitor cells (CD34+CD133+Flk-1+) in endarterectomized tissue of patients with chronic thromboembolic pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 296:L870–L878. 2009. View Article : Google Scholar : PubMed/NCBI
32	Otto S, Nitsche K, Jung C, Kryvanos A, Zhylka A, Heitkamp K, Gutiérrez-Chico JL, Goebel B, Schulze PC, Figulla HR and Poerner TC: Endothelial progenitor cells and plaque burden in stented coronary artery segments: An optical coherence tomography study six months after elective PCI. BMC Cardiovasc Disord. 17:1032017. View Article : Google Scholar : PubMed/NCBI
33	Golab-Janowska M, Paczkowska E, Machalinski B, Kotlega D, Meller A, Safranow K, Wankowicz P and Nowacki P: Elevated inflammatory parameter levels negatively impact populations of circulating stem cells (CD133+), early endothelial progenitor cells (CD133+/VEGFR2+), and fibroblast growth factor in stroke patients. Curr Neurovasc Res. 16:19–26. 2019. View Article : Google Scholar : PubMed/NCBI
34	Skrzypkowska M, Słomiński B, Ryba-Stanisławowska M, Gutknecht P and Siebert J: Circulating CD34+ and CD34+VEGFR2+ progenitor cells are associated with KLOTHO KL-VS polymorphism. Microvasc Res. 119:1–6. 2018. View Article : Google Scholar : PubMed/NCBI
35	Kleinbongard P and Weber AA: Impaired interaction between platelets and endothelial progenitor cells in diabetic patients. Basic Res Cardiol. 103:569–571. 2008. View Article : Google Scholar : PubMed/NCBI